The plant cell growth company
Plant-Based Foods are the future, and our sustainable biofarming technology enables us to produce specific types of plant cells without having to grow the entire plant. We have a robust product pipeline that will deliver finger-print consistent, higher-quality, and lower-cost ingredients for pharmaceutical, nutraceutical, and supplement producers.
BioHarvest Sciences has a clear Path to Commercialization:
- Dec 23, 2020 – First significant B2B US sale announced with Designs For Health and Batory Foods
- Q4 2020 – Israel e-commerce launch exceeds projections – US B2C launch expected in April 2021
- September 2020 – US Distribution agreement with Batory Foods for up to $18 Million of Vinia over 7 years
- Manufacturing agreement with Sugart to provide 20 Ton capacity facility in Q3, 2021
- Over $30 Million CAD spent on Research and Development
- Patented technology
- Proven Management team on both Product Development and Commercialization
- Low Cap Ex alternative to traditional agriculture that will allow scalable production of ingredients such as hemp based CBD, grape, olive, and pomegranate products
Recent News Releases
Investor Inquiries
-
Ilan Sobel
CEO-
E-MAIL
Ilan@bioharvest.com
-
-
David Ryan
VP Investor Relations-
E-MAIL
dave@bioharvest.com -
PHONE
CA - 1-604-622-1186
-
-
Justin Meiklem
Investor Relations-
E-MAIL
justin@bioharvest.com -
PHONE
CA - 778-686-3855
-
